methylprednisolone acetate has been researched along with Acquired Laryngeal Stenosis in 2 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Perepelitsyn, I | 1 |
Shapshay, SM | 1 |
Campbell, BH | 1 |
Dennison, BF | 1 |
Durkin, GE | 1 |
Strigenz, MA | 1 |
Toohill, RJ | 1 |
2 other studies available for methylprednisolone acetate and Acquired Laryngeal Stenosis
Article | Year |
---|---|
Endoscopic treatment of laryngeal and tracheal stenosis-has mitomycin C improved the outcome?
Topics: Administration, Topical; Adolescent; Adult; Aged; Alkylating Agents; Anti-Inflammatory Agents; Cohor | 2004 |
Early and late dilatation for acquired subglottic stenosis.
Topics: Animals; Cephalexin; Dilatation; Dogs; Laryngostenosis; Methylprednisolone; Methylprednisolone Aceta | 1986 |